About Minipharm Pharmaceuticals.
Minipharm Pharmaceuticals. is a publicly listed company based in Cairo (Egypt) founded in 1958, and was acquired by ProBioGen AG in June 2010. It operates as a pharma and biopharma products are manufactured by Minipharm. Minipharm Pharmaceuticals. has completed 1 acquisition, including ProBioGen AG. Its focus areas include Diversified Pharmaceuticals and Drugs.
Company details
Minipharm Pharmaceuticals was founded in 1958 in Masr Al Jadidah, Egypt, within the pharmaceuticals sector. Small molecule formulations are produced across categories including biogenetics, orthopedics, dermatology, ophthalmology, cardiology, gastroenterology, and urogynecology. Contract development and manufacturing services are provided via its German subsidiary, probiogen AG, supporting biopharma operations internationally.
- Headquarters Cairo, Egypt
- Stage Acquired
- SectorsHealthcare
- Website category Health · Pharmacy
- Email••••••••
- Website minapharm.com
- Social LinkedIn Facebook Instagram YouTube
- Acquired by ProBioGen AG (Jun 2010)
- Legal Name Minapharm Pharmaceuticals
- Annual Revenue$5.66 B45.55as on Dec 31, 2024
- Net Profit$128.22 M0as on Dec 31, 2024
- EBITDA$982.65 M119.03as on Dec 31, 2024
- InvestorsProBioGen AG
& 1 more
- Investments & Acquisitions
- Acquired byProBioGen AG
(Jun 2010)
Apps and channels of Minipharm Pharmaceuticals.
its YouTube channel Minapharm Pharmaceuticals has 2.14K subscribers and 30 videos.
Videos from Minipharm Pharmaceuticals.
The most watched videos on Minipharm Pharmaceuticals.'s YouTube channel, Minapharm Pharmaceuticals (2.14K subscribers). Click a video to play it here.
More on Minapharm Pharmaceuticals.
Funding Insights of Minipharm Pharmaceuticals.
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Minipharm Pharmaceuticals. with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2015 | – | Private Equity Round | – | – |
2 investors in total: 2 institutional.
Investors in Minipharm Pharmaceuticals.
Minipharm Pharmaceuticals. has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include ProBioGen AG and PENM Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Vietnamese companies with potential are invested in by PENM Partners. | – | penmpartners.com | Ho Chi Minh City, Vietnam | |
Contract development and manufacturing organization focussed on therapeutic proteins/antibodies, viral vaccines and biosimilars | 1994 | probiogen.de | Berlin, Germany |
Investor details for Minipharm Pharmaceuticals.
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
IPO & Listings of Minipharm Pharmaceuticals.
Minipharm Pharmaceuticals. is a publicly listed company on the EGX with ticker symbol MIPH in Egypt, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date11 Jan 2004
- Listed onEGX: MIPH
- Listed entityMinapharm Pharmaceuticals
- Exchange sectorHealth technology
- ISINEGS380G1C011
- Share price795.49 EGP (+3.99% on the day) · 2026-10-14
- Market capitalisation8,685,037,526.00 EGP
- Dividend yield0.32%
- Volume (last session)5
Financials of Minipharm Pharmaceuticals.
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2024 | 5.66B EGP | 128.2M EGP | 982.6M EGP |
| 2023 | 3.89B EGP | -55.4M EGP | 448.6M EGP |
| 2022 | 3.62B EGP | 589.9M EGP | 989.2M EGP |
| 2021 | 3.01B EGP | 466.4M EGP | 772.5M EGP |
| 2020 | 2.36B EGP | 300.8M EGP | 562.9M EGP |
Detailed financial statements for Minipharm Pharmaceuticals.
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Minipharm Pharmaceuticals.
Minipharm Pharmaceuticals. has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ProBioGen AG.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Contract development and manufacturing organization focussed on therapeutic proteins/antibodies, viral vaccines and biosimilars | probiogen.de | Berlin, Germany | 1994 | Jun 2010 | $37M |
Complete acquisition details for Minipharm Pharmaceuticals.
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Minipharm Pharmaceuticals.
5 dated milestones of Minipharm Pharmaceuticals. across 57 years, from founding to its latest funding, stage changes and deals.
- Founded Minipharm Pharmaceuticals. is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires ProBioGen AG.
- Exit Acquired by ProBioGen AG.
- Funding First funding round.
Web traffic of Minipharm Pharmaceuticals.
The website of Minipharm Pharmaceuticals. (minapharm.com) receives about 3.7K visits a month and ranks #7,384,185 among all websites worldwide, #5,248 in Pharmacy.
- Monthly visits3.7K
▲ 131.4% vs previous month
- Global rank#7,384,185
among all websites
- Category rank#5,248
Health · Pharmacy
- Bounce rate36%
- Pages per visit3.3
- Average visit2 min 42 sec
- DevicesDesktop 63% · Mobile 37%
Websites whose visitors overlap most with Minipharm Pharmaceuticals.. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| preparationh.com | 100% | – | #565,231 | View details | |
dawabazar.in | dawabazar.in | 100% | – | – | – |
drugbank.ca | drugbank.ca | 100% | – | – | – |
| diagnosia.com | 100% | 7.5K | #2,113,690 | View details | |
seif-online.com | seif-online.com | 82% | – | #270,363 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for Minipharm Pharmaceuticals.
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Minipharm Pharmaceuticals. (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Minipharm Pharmaceuticals.
Complete news archive for Minipharm Pharmaceuticals.
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Minipharm Pharmaceuticals.
Minipharm Pharmaceuticals. was founded in 1958 and raised its 1st funding round 57 years after it was founded.
Minipharm Pharmaceuticals. is headquartered in Cairo, Egypt. It is registered at Cairo, Cairo Governorate, Egypt.
Minipharm Pharmaceuticals was founded in 1958 in Masr Al Jadidah, Egypt, within the pharmaceuticals sector. Small molecule formulations are produced across categories including biogenetics, orthopedics, dermatology, ophthalmology, cardiology, gastroenterology, and urogynecology. Contract development and manufacturing services are provided via its German subsidiary, probiogen AG, supporting biopharma operations internationally.
Yes, Minipharm Pharmaceuticals. is publicly traded on EGX under the ticker symbol MIPH.
Minipharm Pharmaceuticals. has made 1 acquisition, including ProBioGen AG.
Minipharm Pharmaceuticals. has 2 investors. Key investors include ProBioGen AG, and PENM Partners.
Yes. Minipharm Pharmaceuticals. was acquired by ProBioGen AG in June 2010.